Distinguishing Non-Small Cell Lung Adenocarcinoma Patients from Squamous Cell Carcinoma Patients and Control Individuals Using Serum Profiling

被引：6
|
作者：
Hocker, James R. [1 ]
Peyton, Marvin D. [2 ]
Lerner, Megan R. [2 ,3 ]
Lightfoot, Stan A. [3 ,4 ]
Hanas, Rushie J. [1 ]
Brackett, Daniel J. [2 ,3 ]
Hanas, Jay S. [1 ,2 ,3 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA
[3] Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA
来源：
CANCER INVESTIGATION | 2012年 / 30卷 / 02期
关键词：
Non-small cell lung cancer; Adenocarcinoma; Squamous cell carcinoma; Serum profiling; Early detection; Predictive value analysis; Electrospray mass spectrometry; OVARIAN-CANCER; IDENTIFICATION; SPECTROMETRY; BIOMARKERS; PROTEOMICS; DISCOVERY;
D O I：
10.3109/07357907.2011.633294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. Sera were obtained from 19 adenocarcinoma patients, 24 squamous cell carcinoma patients, and 21 controls. Identifications of significant mass-to-charge ratio (m/z) peak differences between these groups were performed using t-tests. A "leave one out" cross-validation procedure yielded discriminatory lung adenocarcinoma versus squamous cell carcinoma p and ROC curve values of < .0001 and 0.92, respectively. Test sensitivity and specificity were 84% and 79%, respectively. This approach could aid in lung cancer diagnosis and sub-typing.
引用
收藏
页码：180 / 188
页数：9
相关论文
共 50 条
  • [21] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76
  • [22] Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"
    Shigeta, Naoko
    Yokose, Tomoyuki
    Murakami, Shuji
    Isaka, Tetsuya
    Shinada, Kanako
    Yoshioka, Emi
    Narita, Atsuya
    Katakura, Kengo
    Kondo, Tetsuro
    Kato, Terufumi
    Nagashima, Takuya
    Saito, Haruhiro
    Ito, Hiroyuki
    THORACIC CANCER, 2024, 15 (06) : 458 - 465
  • [23] Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma
    Yoshino, I
    Osoegawa, A
    Yohena, T
    Kameyama, T
    Oki, E
    Oda, S
    Maehara, Y
    RESPIRATORY MEDICINE, 2005, 99 (03) : 308 - 312
  • [24] MULTIPLEXED ANALYSIS OF LUNG CANCER FOR DISTINGUISHING ADENOCARCINOMA FROM SQUAMOUS CELL CARCINOMA
    Kaanumalle, Lakshmi S.
    Kamath, Vidya
    Al-Kofahi, Yousef
    Bove, Kathleen
    Beck, Rod
    Hollman, Denise
    Ginty, Fiona
    Kim, Edward
    Sarachan, Brion D.
    Lazare, Mike
    Lowes, Christina
    Ring, Brian
    Ong, Teng J.
    Li, Qing
    Santamaria-Pang, Alberto
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S453 - S454
  • [25] Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma
    Zhan, Cheng
    Yan, Li
    Wang, Lin
    Sun, Yang
    Wang, Xingxing
    Lin, Zongwu
    Zhang, Yongxing
    Shi, Yu
    Jiang, Wei
    Wang, Qun
    JOURNAL OF THORACIC DISEASE, 2015, 7 (08) : 1398 - +
  • [26] Gene expression profiling identifies unique molecular signature of non-small cell lung cancer cell lines derived from adenocarcinoma or squamous cell carcinoma tumor specimens
    Puri, Sachin
    Bhaskar, Bhattacharva
    Joshi, Bharat H.
    Moudgil, Tarsem L.
    Ross, Helen
    Urba, Walter J.
    Fox, Bernard A.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 864 - 864
  • [27] The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
    Hsiang-Ling Ho
    Hua-Lin Kao
    Yi-Chen Yeh
    Teh-Ying Chou
    Diagnostic Pathology, 14
  • [28] The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
    Ho, Hsiang-Ling
    Kao, Hua-Lin
    Yeh, Yi-Chen
    Chou, Teh-Ying
    DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [29] Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma
    Tomoko Yamagishi
    Katsuhiko Shimizu
    Nobuaki Ochi
    Hiromichi Yamane
    Isao Irei
    Yoshito Sadahira
    Nagio Takigawa
    Mikio Oka
    Masao Nakata
    Diagnostic Pathology, 9
  • [30] The prognostic impact of postoperative decrease in serum albumin on patients with non-small cell lung carcinoma
    Kinoshita, Fumihiko
    Tagawa, Tetsuzo
    Yamashita, Takanori
    Matsubara, Taichi
    Toyokawa, Goji
    Takada, Kazuki
    Oba, Taro
    Osoegawa, Atsushi
    Yamazaki, Koji
    Takenoyama, Mitsuhiro
    Takeo, Sadanori
    Shimokawa, Mototsugu
    Nakashima, Naoki
    Mori, Masaki
    CANCER SCIENCE, 2021, 112 : 500 - 500
12345